DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.

ABSTRACT: Type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), and heart failure (HF)-along with their associated risk factors-have overlapping etiologies, and two or more of these conditions frequently occur in the same patient. Many recent cardiovascular outcome trials (CVOTs) have demonstrated the benefits of agents originally developed to control T2D, ASCVD, or CKD risk factors, and these agents have transcended their primary indications to confer benefits across a range of conditions. This evolution in CVOT evidence calls for practice recommendations that are not constrained by a single discipline to help clinicians manage patients with complex conditions involving diabetes, cardiorenal, and/or metabolic (DCRM) diseases. The ultimate goal for thes

SUBMITTER: Handelsman Y 

PROVIDER: S-EPMC9803322 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature